Skip to content
Safety ProfileEvidence-Based

Adrenomedullin Side Effects

Honest, evidence-based safety analysis for Adrenomedullin. Frequency data, severity classification, data limitations, and what we genuinely don't know.

Quick Answer

Adrenomedullin's primary side effects stem from its potent vasodilatory action. Hypotension, tachycardia, flushing, and headache are common. Excessive diuresis is rare. Severe hypotension requiring vasopressor support is a serious potential risk. Clinical trials closely monitor blood pressure and heart rate to manage these effects.

Data Context: What We Actually Know

Important: data limitations

Side effect data is primarily derived from clinical trials using intravenous adrenomedullin or Adrecizumab. Long-term safety data is limited. The effects of prolonged exposure to elevated MR-proADM levels are also not fully understood.

Side Effects by Severity

MildModerateSevere / Serious
HypotensionModerate

Frequency: Common

Due to potent vasodilation. Requires blood pressure monitoring.

TachycardiaMild

Frequency: Common

Reflex response to vasodilation. Usually transient.

Flushing and facial warmthMild

Frequency: Common

Vasodilation-related effect. Self-limiting.

HeadacheMild

Frequency: Common

Vasodilation-related. Usually mild and self-resolving.

Severe hypotension requiring vasopressor supportSevere / Serious

Frequency: Rare

Requires immediate medical intervention.

Excessive diuresis and natriuresisModerate

Frequency: Rare

Monitor fluid balance and electrolytes.

Contraindications

  • Pre-existing hypotension
  • Hypovolemia
  • Known hypersensitivity to adrenomedullin

Drug Interactions

No formal pharmacokinetic drug interaction studies have been conducted for most research peptides. The interactions below are theoretical, mechanism-based, or derived from limited case reports.
  • Vasodilators (e.g., nitrates, calcium channel blockers): Increased risk of hypotension
  • Diuretics: Increased risk of excessive diuresis and electrolyte imbalances
  • ACE inhibitors and ARBs: May potentiate hypotensive effects

Frequently Asked Questions

What are the most common side effects of adrenomedullin?
The most common side effects are related to its vasodilatory action, including hypotension, tachycardia, flushing, and headache. These are typically mild to moderate in severity.
Can adrenomedullin cause dangerously low blood pressure?
Yes, severe hypotension requiring vasopressor support is a potential risk, although rare. Close blood pressure monitoring is essential during intravenous administration.
Does adrenomedullin interact with other medications?
Adrenomedullin can interact with other vasodilators, diuretics, ACE inhibitors, and ARBs, potentially increasing the risk of hypotension or electrolyte imbalances.
Are there any contraindications for adrenomedullin use?
Contraindications include pre-existing hypotension, hypovolemia, and known hypersensitivity to adrenomedullin.
How are the side effects of adrenomedullin managed?
Side effects are managed through close blood pressure and heart rate monitoring, fluid balance management, and electrolyte correction as needed. Vasopressors may be required in cases of severe hypotension.

References

  1. 1
    Adrenomedullin in cardiovascular disease: from bench to bedside(2005)PubMed ↗
  2. 2
    Adrecizumab (anti-adrenomedullin antibody) in sepsis: AdrenOSS-2 trial results(2020)PubMed ↗
  3. 3
    The haemodynamic effects of adrenomedullin in healthy volunteers.(1998)PubMed ↗

Last updated: 2026-02-19